Efficacy of intensive antiemetic therapy including olanzapine in multiple myeloma patients treated with high-dose melphalan with autologous stem cell transplantation
The four-drug intensive regimen including OLA may improve the antiemetic effect on delayed CINV while also ensuring safety in MM patients undergoing MEL/ASCT.
Authors
- Osamu Hosoya
- Shingo Yamazaki (ORCID: https://orcid.org/0000-0003-3698-5916)
- Sayo Tatsuta
- Yohei Kawasaki (ORCID: https://orcid.org/0000-0002-7474-7647)
- Yuki Shiko (ORCID: https://orcid.org/0000-0002-3959-9343)
- Takeshi Yoshimi
- Junpei Kato
- Kota Ishida (ORCID: https://orcid.org/0000-0002-7550-7194)
- Masayuki Ishikawa (ORCID: https://orcid.org/0000-0002-8510-9392)
- Masashi Uchida (ORCID: https://orcid.org/0000-0002-3171-9208)
- Itsuko Ishii (ORCID: https://orcid.org/0000-0002-0683-6701)
- Tadao Ishida
- Nobuhiro Tsukada
Institutions
- Chiba University (JP)
- Chiba University Hospital (JP)
- Japanese Red Cross Medical Center (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1007/s00520-025-09839-2
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00